| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |